1-4 of 4
Alfonso Marchianò, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Dual Targeted Therapy with the AKT Inhibitor Perifosine and the Multikinase Inhibitor Sorafenib in Patients with Relapsed/Refractory Lymphomas: Final Results of a Phase II Trial

Anna Guidetti, MD, Simonetta Viviani, MD, Alfonso Marchianò, MD, Anna Dodero, MD, Lucia Farina, MD, PhD, Silvia L Locatelli, PhD, Domenico Russo, Pietro Bulian, MD, Roberto Sorasio, MD, Massimo Di Nicola, MD, Laura Giordano, MD, Paolo Corradini, MD, Alessandro M. Gianni, MD, Carmelo Carlo-Stella, MD
Journal: Blood
Blood (2012) 120 (21): 3679.
https://doi.org/10.1182/blood.V120.21.3679.3679
Published: 2012
Journal Articles

Clinical Activity and Safety of the Combined Therapy with the AKT Inhibitor Perifosine and the Multikinase Inhibitor Sorafenib In Heavily Pretreated Patients with Relapsed/Refractory Lymphomas: Preliminary Results of a Phase II Trial

Carmelo Carlo-Stella, MD, Anna Guidetti, MD, Simonetta Viviani, MD, Liliana Devizzi, MD, Paola Matteucci, MD, Alfonso Marchianò, MD, Rodolfo Lanocita, MD, Stefania Zambelli, MD, Roberto Sorasio, MD, Massimo Di Nicola, MD, Paolo Corradini, MD, Alessandro M. Gianni, MD
Journal: Blood
Blood (2010) 116 (21): 2861.
https://doi.org/10.1182/blood.V116.21.2861.2861
Published: 2010
Journal Articles

Preliminary Results of a Phase II Trial with the Multikinase Inhibitor Sorafenib in Heavily Pretreated Patients with Relapsed/Refractory Non-Hodgkin Lymphoma (NHL).

Anna Guidetti, MD, Carmelo Carlo-Stella, MD, Liliana Devizzi, MD, Paola Matteucci, MD, Alfonso Marchianò, MD, Rodolfo Lanocita, MD, Michele Magni, MD, Anna Dodero, MD, Corrado Tarella, MD, Massimo Di Nicola, MD, Paolo Corradini, MD, Alessandro M. Gianni, MD
Journal: Blood
Blood (2009) 114 (22): 1658.
https://doi.org/10.1182/blood.V114.22.1658.1658
Published: 2009
Journal Articles

Phase II Trial of Combination of the Histone Deacetylase Inhibitor ITF2357 and Meclorethamine Demonstrates Clinical Activity and Safety in Heavily Pretreated Patients with Relapsed/Refractory Hodgkin Lymphoma (HL)

Carmelo Carlo-Stella, MD, Anna Guidetti, MD, Simonetta Viviani, MD, Valeria Bonfante, MD, Pinuccia Valagussa, MD, Alfonso Marchianò, MD, Flavio Crippa, MD, Stefania Zambelli, MD, Cinzia Fasola, MD, Paolo Corradini, MD, Corrado Tarella, MD, Massimo Di Nicola, MD, Alessandro M. Gianni, MD
Journal: Blood
Blood (2008) 112 (11): 2586.
https://doi.org/10.1182/blood.V112.11.2586.2586
Published: 2008